Infectious Diseases News and Research

RSS

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 "breakthrough" infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

13 Oct 2022

DTU researchers create a new tool in the fight against resistant bacteria

According to the WHO, antibiotic resistance is one of the biggest threats to public health. DTU researchers have created a new tool in the fight against resistant bacteria that, based on 214,000 microbiome samples, can create an overview of the problem across countries, people and environments.

13 Oct 2022

Novel testing method could simplify widespread tuberculosis screening

Tuberculosis can be tough to detect. Diagnosis usually requires coughing up a sputum sample from the lungs, which can be unpleasant, impractical, and even hazardous.

13 Oct 2022

New malaria vaccine rollout planned in 2023

Researchers say they plan to roll out a new malaria vaccine next year after tests on children in West Africa found it to be up to 80 per cent effective.

13 Oct 2022

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

A clinical trial to evaluate the antiviral drug tecovirimat, also known as TPOXX, in adults and children with monkeypox has begun in the Democratic Republic of the Congo (DRC).

12 Oct 2022

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

The mitochondria is a key energy-producing component of the human cell that plays an important role in cancer cell metabolism.

12 Oct 2022

Study highlights the importance of getting vaccinated for flu

An international team of researchers has demonstrated that among patients hospitalized for influenza, those who were vaccinated had less severe infections, including reducing the odds for children requiring admittance to an intensive care unit by almost half.

12 Oct 2022

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cystic fibrosis (CF) is an inherited disorder that causes severe damage to the lungs and other organs in the body.

11 Oct 2022

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

An experimental approach to enhancing a standard cat allergy treatment made it more effective and faster acting, and the benefits persisted for a year after treatment ended, a study supported by the National Institutes of Health has found.

11 Oct 2022

Watch: What experts advise for seniors living under the long shadow of covid

The covid-19 pandemic casts a long shadow over the lives of older adults and their family caregivers in the United States, even as many people resolve to move on and resume normal activities.

11 Oct 2022

Duke receives federal funding for HIV vaccine research

The Duke Human Vaccine Institute and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

11 Oct 2022

Exploring the possibilities of plasma-based therapies for cancer

Exploring the possibilities of atmospheric-pressure plasmas to develop and consolidate new medical therapies is the main objective of the PlasTHER network, an initiative funded by the European Union under the COST Actions.

11 Oct 2022

"Smart surveillance" for viral spillover needed to lessen the consequences of next pandemic

"Smart surveillance" for viral spillover from animals to humans, targeted preparedness and drug and vaccine research, and worldwide cooperation on surveillance and stopping disease spread are required to reduce deaths and lessen the economic consequences of the next pandemic, according to an international team of scientists.

10 Oct 2022

Scientists discover a promising strategy for development of broad-spectrum antiviral therapies

Researchers have identified a promising strategy for development of broad-spectrum antiviral therapies that centers around promoting a strong immune response capable of stopping a number of viruses in their infectious tracks.

10 Oct 2022

Independent Task Force report outlines a One Health approach to address risk factors for future pandemics

The Independent Task Force on COVID-19 and other Pandemics (www.independentcovidtaskforce.org) announced that their report "Pandemic Origins and a One Health Approach to Preparedness and Prevention: Solutions Based on SARS-CoV-2 and Other RNA Viruses" has been published in the Proceedings of the National Academy of Sciences.

10 Oct 2022

Four of 10 Americans report misrepresentation and nonadherence regarding COVID-19 public health measures

Four of 10 Americans surveyed report that they were often less than truthful about whether they had COVID-19 and/or didn't comply with many of the disease's preventive measures during the height of the pandemic, according to a new nationwide study led in part by University of Utah Health scientists.

10 Oct 2022

What is the impact of pre-COVID vaccination on long COVID?

A new study aimed to analyze the impact of pre-COVID-19 vaccination on long COVID diagnosis.

10 Oct 2022

UMSOM researchers identify how multiple genes of SARS-CoV-2 affect disease severity

University of Maryland School of Medicine researchers have identified how multiple genes of SARS-CoV-2 affect disease severity, which could lead to new ways in how we develop future vaccines or develop newer treatments.

7 Oct 2022

Successful rollout of vaccine has led to dramatic reduction in long COVID clinic referrals

Referrals to Cambridge's long COVID clinic fell dramatically in the period August 2021 to June 2022, which researchers say is likely due to the successful rollout of the vaccine.

7 Oct 2022

Study reports low incidence of severe COVID-19 among vaccinated and boosted individuals

A large study of COVID-19 disease following vaccination and booster, published in the Journal of the American Medical Association (JAMA), reports surprisingly low incidence, especially in individuals younger than 65 years of age with no high-risk conditions.

6 Oct 2022

Infectious Diseases News and Research

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

DTU researchers create a new tool in the fight against resistant bacteria

Novel testing method could simplify widespread tuberculosis screening

New malaria vaccine rollout planned in 2023

Clinical trial to evaluate antiviral drug for monkeypox begins in the Democratic Republic of the Congo

Mic60-low gene signature may be a simple tool to estimate pancreatic cancer risk

Study highlights the importance of getting vaccinated for flu

Clinical trial to test the safety, efficacy of bacteriophages for treating P. aeruginosa infections in CF patients

Cat allergen immunotherapy works better and more quickly when combined with monoclonal antibody

Watch: What experts advise for seniors living under the long shadow of covid

Duke receives federal funding for HIV vaccine research

Exploring the possibilities of plasma-based therapies for cancer

"Smart surveillance" for viral spillover needed to lessen the consequences of next pandemic

Scientists discover a promising strategy for development of broad-spectrum antiviral therapies

Independent Task Force report outlines a One Health approach to address risk factors for future pandemics

Four of 10 Americans report misrepresentation and nonadherence regarding COVID-19 public health measures

What is the impact of pre-COVID vaccination on long COVID?

UMSOM researchers identify how multiple genes of SARS-CoV-2 affect disease severity

Successful rollout of vaccine has led to dramatic reduction in long COVID clinic referrals

Study reports low incidence of severe COVID-19 among vaccinated and boosted individuals

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News